AF Regulatory Compliance & Standards 3

Question 1

Under MIPS (Merit-based Incentive Payment System), which quality measure specifically addresses appropriate anticoagulation prescribing in non-valvular AF patients?

Accepted Answer

Quality Measure #236

Answer

MIPS Quality Measure #236 (Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy) tracks appropriate anticoagulation in eligible AF patients.

Question 2

The HAS-BLED scoring tool is used in AF management to assess risk of:

Accepted Answer

Major bleeding complications

Answer

HAS-BLED estimates the annual risk of major bleeding in anticoagulated AF patients, helping clinicians weigh anticoagulation risks versus benefits.

Question 3

According to ACC/AHA guidelines, which of the following is a Class I indication for rhythm control strategy in AF?

Accepted Answer

Symptomatic AF where rate control has failed to adequately relieve symptoms

Answer

Symptomatic AF in which rate control fails to relieve symptoms is a Class I indication for pursuing rhythm control to improve quality of life.

Question 4

HIPAA Security Rule requirements most directly impact AF clinic operations by mandating:

Accepted Answer

Administrative, physical, and technical safeguards for electronic protected health information

Answer

The HIPAA Security Rule requires covered entities to implement administrative, physical, and technical safeguards to protect electronic PHI, including AF patient records.

Question 5

Under the 2023 ACC/AHA AF guidelines, anticoagulation is NOT recommended (Class III: Harm) in patients with non-valvular AF who have a CHA2DS2-VASc score of:

Accepted Answer

0 in males or 1 in females

Answer

Anticoagulation is not recommended (Class III) for male patients with CHA2DS2-VASc of 0 or female patients with a score of 1 (sex as the only risk factor), as net benefit is absent.

(AF) Atrial Fibrillation Certification Practice Test

(AF) Atrial Fibrillation Certification Practice Test

AF Regulatory Compliance & Standards 3